| Biological Sciences | Lifetime | 451 | US 267 | 99.94 |
| Medical and Health Sciences | Lifetime | 794 | US 410 | 99.96 |
| Biological Sciences | 2021-2025 | 108 | US 18 | 99.90 |
| Medical and Health Sciences | 2021-2025 | 394 | US 136 | 99.92 |
| Dermatology | Lifetime | 11 | US 6 | 99.90 |
| Immunology | Lifetime | 61 | US 42 | 99.89 |
| Epidemiology | Lifetime | 602 | US 309 | 99.25 |
| Rheumatology | Lifetime | 376 | US 169 | 98.39 |
| Pathology and Forensic Medicine | Lifetime | 447 | US 207 | 98.17 |
| Cell Biology | Lifetime | 786 | US 431 | 94.85 |
| Immunology and Allergy | Lifetime | 717 | US 293 | 84.62 |
| Urology | Lifetime | 723 | US 317 | 80.73 |
| Immunology | 2021-2025 | 9 | US 5 | 99.77 |
| Dermatology | 2021-2025 | 29 | US 8 | 99.55 |
| Rheumatology | 2021-2025 | 85 | US 24 | 97.93 |
| Pathology and Forensic Medicine | 2021-2025 | 141 | US 55 | 96.55 |
| Econometrics and Quantitative Economics | 2021-2025 | 852 | US 236 | 94.49 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 388 | US 154 | 91.06 |
| Epidemiology | 2021-2025 | 978 | US 348 | 89.69 |
| Cell Biology | 2021-2025 | 201 | US 81 | 80.58 |
| Genetics | 2021-2025 | 808 | US 300 | 73.30 |
| Dermatology and Skin Diseases | Lifetime | 5 | US 4 | 99.92 |
| Autoimmune Bullous Skin Diseases | Lifetime | 4 | US 3 | 99.85 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 5 | US 2 | 99.93 |
| Dermatological and Skeletal Disorders | Lifetime | 5 | US 4 | 99.64 |
| Pharmaceutical studies and practices | Lifetime | 13 | US 9 | 99.66 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 40 | US 19 | 99.31 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 42 | US 19 | 99.27 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 222 | US 111 | 99.30 |
| Nail Diseases and Treatments | Lifetime | 56 | US 31 | 99.26 |
| Retinoids in leukemia and cellular processes | Lifetime | 68 | US 42 | 99.05 |
| Skin Protection and Aging | Lifetime | 67 | US 32 | 99.06 |
| Spondyloarthritis Studies and Treatments | Lifetime | 55 | US 15 | 99.22 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 115 | US 37 | 99.07 |
| Asthma and respiratory diseases | Lifetime | 356 | US 137 | 99.10 |
| Skin and Cellular Biology Research | Lifetime | 68 | US 30 | 98.61 |
| Autoimmune and Inflammatory Disorders | Lifetime | 58 | US 23 | 98.93 |
| Pregnancy and Medication Impact | Lifetime | 120 | US 56 | 98.29 |
| Urticaria and Related Conditions | Lifetime | 157 | US 60 | 98.35 |
| Drug-Induced Adverse Reactions | Lifetime | 140 | US 47 | 97.61 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 376 | US 109 | 98.41 |
| Allergic Rhinitis and Sensitization | Lifetime | 428 | US 123 | 98.28 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 802 | US 330 | 96.98 |
| Cancer and Skin Lesions | Lifetime | 402 | US 197 | 96.86 |
| Cutaneous Melanoma Detection and Management | Lifetime | 414 | US 190 | 97.16 |
| Acne and Rosacea Treatments and Effects | Lifetime | 157 | US 75 | 96.88 |
| Complementary and Alternative Medicine Studies | Lifetime | 333 | US 136 | 95.51 |
| Oral Health Pathology and Treatment | Lifetime | 478 | US 149 | 95.97 |
| Contact Dermatitis and Allergies | Lifetime | 466 | US 116 | 96.33 |
| melanin and skin pigmentation | Lifetime | 546 | US 207 | 95.05 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 777 | US 252 | 94.30 |
| Therapeutic Uses of Natural Elements | Lifetime | 181 | US 63 | 93.07 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 108 | US 34 | 93.98 |
| Skin Diseases and Diabetes | Lifetime | 253 | US 106 | 92.71 |
| Dermatologic Treatments and Research | Lifetime | 760 | US 316 | 93.60 |
| Hair Growth and Disorders | Lifetime | 508 | US 181 | 91.17 |
| Biosimilars and Bioanalytical Methods | Lifetime | 897 | US 331 | 89.14 |
| Dupuytren's Contracture and Treatments | Lifetime | 243 | US 103 | 87.04 |
| Dermatological and COVID-19 studies | Lifetime | 399 | US 104 | 84.58 |
| Chemotherapy-related skin toxicity | Lifetime | 703 | US 324 | 83.21 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 2 | US 1 | 99.88 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 4 | US 2 | 99.73 |
| Dermatology and Skin Diseases | 2021-2025 | 12 | US 6 | 99.72 |
| Pharmaceutical studies and practices | 2021-2025 | 8 | US 4 | 98.84 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 102 | US 29 | 98.50 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 17 | US 7 | 97.09 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 40 | US 10 | 98.58 |
| Asthma and respiratory diseases | 2021-2025 | 152 | US 38 | 98.56 |
| Urticaria and Related Conditions | 2021-2025 | 65 | US 15 | 97.04 |
| Oral Health Pathology and Treatment | 2021-2025 | 72 | US 6 | 94.91 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 241 | US 68 | 95.89 |
| Drug-Induced Adverse Reactions | 2021-2025 | 104 | US 33 | 92.56 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 315 | US 69 | 92.86 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 203 | US 74 | 91.34 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 225 | US 66 | 90.81 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 527 | US 85 | 92.52 |
| melanin and skin pigmentation | 2021-2025 | 190 | US 41 | 87.85 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 502 | US 133 | 89.16 |
| Mast cells and histamine | 2021-2025 | 167 | US 39 | 88.31 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 284 | US 87 | 80.77 |
| Complementary and Alternative Medicine Studies | 2021-2025 | 368 | US 76 | 79.81 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 709 | US 150 | 76.44 |
| Dupuytren's Contracture and Treatments | 2021-2025 | 77 | US 26 | 68.39 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 483 | US 148 | 65.20 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 812 | US 271 | 62.48 |
| Phosphodiesterase function and regulation | 2021-2025 | 204 | US 41 | 59.91 |
| Hair Growth and Disorders | 2021-2025 | 853 | US 198 | 62.12 |
| Dermatological and COVID-19 studies | 2021-2025 | 491 | US 76 | 60.64 |
| Hedgehog Signaling Pathway Studies | 2021-2025 | 882 | US 237 | 48.66 |
| Dermatological and Skeletal Disorders | 2021-2025 | 739 | US 180 | 43.77 |